Literature DB >> 27900604

Assessment of interstitial lung disease in Sjögren's syndrome by lung ultrasound: a pilot study of correlation with high-resolution chest tomography.

Pablo Guisado Vasco1, Gonzalo de Luna Cardenal2, Isabel Martín Garrido3, José Manuel Luque Pinilla3, Guadalupe Fraile Rodríguez4, Juan José Nava Mateo4, Daniel Carnevalli Ruiz5.   

Abstract

The background of this study is to assess the accuracy of lung ultrasound (LUS) to diagnose interstitial lung disease (ILD) in Sjögren's syndrome (Sjs), in patients who have any alterations in pulmonary function tests (PFT) or respiratory symptoms. LUS was correlated with chest tomography (hrCT), considering it as the imaging gold standard technique to diagnose ILD. This is a pilot, multicenter, cross-sectional, and consecutive-case study. The inclusion criteria are ≥18 years old, Signs and symptoms: according to ACEG 2002 criteria, respiratory symptoms (dyspnea, cough), or any alterations in PFR. LUS was done following the International Consensus Conference on Lung Ultrasound protocol for interstitial syndrome (B pattern). Of the 50 patients in follow-up, 13 (26%) met the inclusion criteria. All were women with age 63.62 years (range 39-88). 78.6% of the cases had primary Sjs (SLE, RA, n = 2). The intra-rater reliability k is 1, according to Gwet's Ac1 and GI index (probability to concordance-e(K)-, by Cohen, of 0.52). LUS has a sensitivity of 1 (95% CI 0.398-1.0), specificity of 0.89 (95% CI 0.518-0.997), and a positive probability reason of 9.00 (95% CI 7.1-11.3) to detect ILD. The correlation of Pearson is r = 0.84 (p < 0.001). To check the accuracy of LUS to diagnose ILD, a completely bilateral criterion of yes/no for interstitial pattern was chosen, AUC reaches significance, 0.94 (0.07) (95% CI 0.81-1.0, p = 0.014). LUS reaches an excellent correlation to hrCT in Sjs affected with ILD, and might be a useful technique in daily clinical practice for the assessment of pulmonary disease in the sicca syndrome.

Entities:  

Keywords:  CT scanning; Diagnostic imaging; Disease activity; Respiratory; Sjögren’s syndrome; Ultrasonography

Mesh:

Year:  2016        PMID: 27900604     DOI: 10.1007/s11739-016-1582-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  16 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  International evidence-based recommendations for point-of-care lung ultrasound.

Authors:  Giovanni Volpicelli; Mahmoud Elbarbary; Michael Blaivas; Daniel A Lichtenstein; Gebhard Mathis; Andrew W Kirkpatrick; Lawrence Melniker; Luna Gargani; Vicki E Noble; Gabriele Via; Anthony Dean; James W Tsung; Gino Soldati; Roberto Copetti; Belaid Bouhemad; Angelika Reissig; Eustachio Agricola; Jean-Jacques Rouby; Charlotte Arbelot; Andrew Liteplo; Ashot Sargsyan; Fernando Silva; Richard Hoppmann; Raoul Breitkreutz; Armin Seibel; Luca Neri; Enrico Storti; Tomislav Petrovic
Journal:  Intensive Care Med       Date:  2012-03-06       Impact factor: 17.440

3.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

Review 4.  Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.

Authors:  Y Alamanos; N Tsifetaki; P V Voulgari; A I Venetsanopoulou; C Siozos; A A Drosos
Journal:  Rheumatology (Oxford)       Date:  2005-12-06       Impact factor: 7.580

5.  Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.

Authors:  Florentine C Moazedi-Fuerst; Sonja Kielhauser; Kerstin Brickmann; Norbert Tripolt; Michael Meilinger; Andre Lufti; Winfried Graninger
Journal:  Clin Exp Rheumatol       Date:  2015-01-29       Impact factor: 4.473

6.  Ultrasound in the assessment of pulmonary fibrosis in connective tissue disorders: correlation with high-resolution computed tomography.

Authors:  Marika Tardella; Marwin Gutierrez; Fausto Salaffi; Marina Carotti; Alarico Ariani; Chiara Bertolazzi; Emilio Filippucci; Walter Grassi
Journal:  J Rheumatol       Date:  2012-07-01       Impact factor: 4.666

7.  Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.

Authors:  Tatiana Barskova; Luna Gargani; Serena Guiducci; Silvia Bellando Randone; Cosimo Bruni; Giulia Carnesecchi; Maria Letizia Conforti; Francesco Porta; Alberto Pignone; Davide Caramella; Eugenio Picano; Marco Matucci Cerinic
Journal:  Ann Rheum Dis       Date:  2012-05-15       Impact factor: 19.103

8.  Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease.

Authors:  Antonietta Gigante; Filippo Rossi Fanelli; Silvio Lucci; Giuseppe Barilaro; Silvia Quarta; Biagio Barbano; Antonello Giovannetti; Antonio Amoroso; Edoardo Rosato
Journal:  Intern Emerg Med       Date:  2015-10-22       Impact factor: 3.397

9.  Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Raphaèle Seror; Hendrika Bootsma; Simon J Bowman; Thomas Dörner; Jacques-Eric Gottenberg; Xavier Mariette; Elke Theander; Stefano Bombardieri; Salvatore De Vita; Thomas Mandl; Wan-Fai Ng; Aike Kruize; Athanasios Tzioufas; Claudio Vitali
Journal:  Rheumatology (Oxford)       Date:  2015-07-31       Impact factor: 7.580

10.  A comparison of Cohen's Kappa and Gwet's AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples.

Authors:  Nahathai Wongpakaran; Tinakon Wongpakaran; Danny Wedding; Kilem L Gwet
Journal:  BMC Med Res Methodol       Date:  2013-04-29       Impact factor: 4.615

View more
  6 in total

Review 1.  Ultrasound as a potential tool for the assessment of interstitial lung disease in rheumatic patients. Where are we now?

Authors:  Marwin Gutierrez; Marika Tardella; Luis Rodriguez; Jaime Mendoza; Denise Clavijo-Cornejo; Antonio García; Chiara Bertolazzi
Journal:  Radiol Med       Date:  2019-07-02       Impact factor: 3.469

Review 2.  Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions?

Authors:  Domenico Sambataro; Gianluca Sambataro; Ylenia Dal Bosco; Davide Campagna; Riccardo Polosa
Journal:  Intern Emerg Med       Date:  2017-03-04       Impact factor: 3.397

Review 3.  Use of ultrasound to diagnose and monitor interstitial lung disease in rheumatic diseases.

Authors:  Esther F Vicente-Rabaneda; David A Bong; Santos Castañeda; Ingrid Möller
Journal:  Clin Rheumatol       Date:  2021-06-23       Impact factor: 2.980

Review 4.  Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review.

Authors:  YuKai Wang; Luna Gargani; Tatiana Barskova; Dan E Furst; Marco Matucci Cerinic
Journal:  Arthritis Res Ther       Date:  2017-09-18       Impact factor: 5.156

5.  A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis.

Authors:  Hai Qin Xie; Wei Wei Zhang; De Sheng Sun; Xiang Mei Chen; Shu Fang Yuan; Zheng Hua Gong; Li Liu
Journal:  Arthritis Res Ther       Date:  2019-04-11       Impact factor: 5.156

6.  Quantitative assessment of interstitial lung disease in Sjögren's syndrome.

Authors:  Pablo Guisado-Vasco; Mario Silva; Miguel Angel Duarte-Millán; Gianluca Sambataro; Chiara Bertolazzi; Mauro Pavone; Isabel Martín-Garrido; Oriol Martín-Segarra; José Manuel Luque-Pinilla; Daniele Santilli; Domenico Sambataro; Sebastiano E Torrisi; Ada Vancheri; Marwin Gutiérrez; Mayra Mejia; Stefano Palmucci; Flavio Mozzani; Jorge Rojas-Serrano; Carlo Vanchieri; Nicola Sverzellati; Alarico Ariani
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.